HYHanyang Yu

Hanyang Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanyang Yu has a total of 127 co-authors. Here are the top co-authors by number of shared publications:

  • Zhe Li

    State Key Laboratory of Analytical Chemistry for Life Science Department of Biomedical Engineering College of Engineering and Applied Sciences Nanjing University Nanjing Jiangsu 210023 P. R. China

    18 shared publications
  • Yueyao Wang

    State Key Laboratory of Coordination Chemistry, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center at Nanjing University, Nanjing University, Nanjing, China

    9 shared publications
  • Jintao Yang

    State Key Laboratory of Coordination Chemistry, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), Jiangsu Key Laboratory of Artificial Functional Materials, Nanjing University, Nanjing 210023, China

    8 shared publications
  • Juan Wang

    Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School Nanjing University Nanjing Jiangsu China

    8 shared publications
  • Yao Wang

    State Key Laboratory of Coordination Chemistry, Department of Biomedical Engineering, College of Engineering and Applied Sciences, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center at Nanjing University

    7 shared publications
  • Ze Zhang

    State Key Laboratory of Coordination Chemistry Department of Biomedical Engineering College of Engineering and Applied Sciences Chemistry and Biomedicine Innovation Center (ChemBIC) Jiangsu Key Laboratory of Artificial Functional Materials Nanjing University Nanjing Jiangsu 210023 China

    6 shared publications

Latest Publications

  • Open Access

    Empowering DNA nanotechnology with xeno-nucleic acids

    by Yueyao Wang, Alexander I. Taylor, Hanyang Yu

  • Open Access

    Chemically Modified DNAzyme with Enhanced Activity for Sensitive MicroRNA Imaging in Live Cells

    by Jiawen Chen, Juan Wang, Jiahuan Wang, Fulong Wang, Wenyu Cheng, Siqi Chen, Rui Mo, Hanyang Yu

    As critical regulators of gene expression, microRNAs (miRNAs) are key biomarkers and therapeutic targets in cancer. However, current methods for intracellular miRNA imaging are often limited by poor sensitivity and operational complexity. In this study, we identified a site-specifically modified DNAzyme variant, 11Bn, which exhibits up to 7-fold higher catalytic activity than the wild-type 8-17 through systematic screening. Using this variant, we constructed a DNAzyme-based sensor for miRNA-21 imaging in living cells. The sensor achieves a limit of detection of 7.89 nM, threefold lower than that of the wild-type sensor, and enables sensitive visualization of intracellular miRNA-21 without signal amplification. Moreover, it can capture dynamic changes in miRNA levels within cells, providing a versatile molecular tool for miRNA imaging and related biomedical applications.


  • Sanger Sequencing of Xeno‐Nucleic Acid

    by Yueyao Wang, Ze Zhang, Lekang Chen, Jing Zhu, Shunfu Qin, Dongying Wei, Jibao Zhang, Feng Han, Fulong Wang, Qi Lin, et al.

    Xeno‐nucleic acids (XNAs) offer biostable genetic polymers for biotechnology and information technology, but are incompatible with prevailing DNA sequencing methodologies. Here we report a Sanger sequencing approach tailored for XNA, enabling direct readout of XNA strands up to 50 bases. This new method relies on a Bst DNA polymerase mutant, which not only recognizes XNA as a template but also efficiently incorporates dideoxyribonucleoside triphosphate (ddNTP) substrates, facilitating sequencing of XNA by synthesis of complementary DNA. The Bst F710Y mutant exhibits at least two orders of magnitude higher activity in catalyzing ddNTP incorporation. Our method demonstrates accurate sequence determination of diverse XNA strands of distinct backbone chemistries such as TNA and FANA. Lastly, we showcase proof‐of‐concept automated XNA sequencing on a genetic analyzer instrument, by leveraging Bst mutant's ability to stochastically incorporate BigDye‐labeled ddNTP substrates in a single reaction. This work establishes a direct sequencing platform for XNA employing a chain termination strategy, and lays a foundation for future de novo identification of functional XNA and development of XNA‐based data storage system.

  • Sanger Sequencing of Xeno‐Nucleic Acid

    by Yueyao Wang, Ze Zhang, Lekang Chen, Jing Zhu, Shunfu Qin, Dongying Wei, Jibao Zhang, Feng Han, Fulong Wang, Qi Lin, et al.

    Xeno‐nucleic acids (XNAs) offer biostable genetic polymers for biotechnology and information technology, but are incompatible with prevailing DNA sequencing methodologies. Here we report a Sanger sequencing approach tailored for XNA, enabling direct readout of XNA strands up to 50 bases. This new method relies on a Bst DNA polymerase mutant, which not only recognizes XNA as a template but also efficiently incorporates dideoxyribonucleoside triphosphate (ddNTP) substrates, facilitating sequencing of XNA by synthesis of complementary DNA. The Bst F710Y mutant exhibits at least two orders of magnitude higher activity in catalyzing ddNTP incorporation. Our method demonstrates accurate sequence determination of diverse XNA strands of distinct backbone chemistries such as TNA and FANA. Lastly, we showcase proof‐of‐concept automated XNA sequencing on a genetic analyzer instrument, by leveraging Bst mutant's ability to stochastically incorporate BigDye‐labeled ddNTP substrates in a single reaction. This work establishes a direct sequencing platform for XNA employing a chain termination strategy, and lays a foundation for future de novo identification of functional XNA and development of XNA‐based data storage system.


  • In Vitro Selection of Threose Nucleic Acid (TNA) Enzymes That Catalyze RNA Transformations

    by Juan Wang, Yueyao Wang, Hanyang Yu

    This article provides a comprehensive set of protocols for the in vitro selection of threose nucleic acid (TNA) enzymes capable of catalyzing RNA cleavage or ligation reactions. The article first outlines the generation of random‐sequence TNA libraries (typically comprising ∼10 14 unique molecules) covalently attached to their RNA substrates via engineered DNA polymerases. It then describes the procedure for isolating catalytically active TNA sequences through affinity chromatography or gel electrophoresis. These sequences are subsequently reverse‐transcribed to cDNA for amplification or sequencing. This set of protocols is primarily designed for selecting RNA‐cleaving and RNA ligase TNA enzymes but can be adapted for the discovery of TNA enzymes that act on DNA substrates or enzymes derived from other xeno‐nucleic acids, provided that requisite nucleoside triphosphates and compatible tool enzymes are available.© 2025 Wiley Periodicals LLC. Basic Protocol 1 : TNA library synthesis Basic Protocol 2 : Selection of RNA‐cleaving TNA enzyme Alternate Protocol : Selection of RNA ligase TNA enzyme Basic Protocol 3 : Reverse transcription of enriched TNA library Basic Protocol 4 : Preparation of template DNA for the next round

  • Novel Aptamer-Drug Conjugate for Targeted Therapy in Triple-Negative Breast Cancer

    by Feng Xu, Jingtong Xu, Feng Han, Ke Wang, Fulong Wang, Hanyang Yu, Xiaoxiang Guan

    Triple-negative breast cancer (TNBC) is a highly aggressive malignancy lacking targeted therapeutic modalities. Aptamers are promising targeting agents with high specificity and affinity. In this study, we identified a chemically modified nucleic acid aptamer (AptT1) that specifically recognized and internalized into TNBC cells. Mechanistic studies revealed that ANXA2 was an essential protein in facilitating AptT1 internalization via clathrin-mediated endocytosis. Furthermore, we constructed an aptamer-drug conjugate (ApDC) to selectively deliver a cytotoxic agent (SN38) to TNBC cells and demonstrated significant efficacy and safety in a TNBC xenograft model. These findings suggest that AptT1-based ApDC holds great potential as an innovative targeted strategy for TNBC.


  • A Threose Nucleic Acid (TNA) Enzyme Catalyzing Native 3′-5′ Ligation of RNA

    by Juan Wang, Feng Han, Ye Zou, Mengqi Wang, Yao Wang, Jia-Yu Chen, Hanyang Yu

    Threose nucleic acid (TNA) is a synthetic genetic polymer of both prebiotic significance and practical utility. Identification of TNA molecules with enzymatic activities (TNAzymes) not only lends experimental support for TNA as a potential primitive catalyst but also offers intrinsically stable biotechnological and biomedical molecular tools. Here, we report the in vitro selection of TNAzymes capable of catalyzing the native 3'-5' ligation of two RNA oligonucleotides. The Zn2+-dependent TNAzyme facilitates the formation of a canonical phosphoester bond between a terminal 3'-hydroxyl group on one substrate and a 5'-triphosphate on the other. Under optimal conditions (pH 7.3 and 23 °C), the TNAzyme exhibits a catalytic rate constant of 0.39 h-1. Lastly, we demonstrate that the TNAzyme-catalyzed ligation of two RNA fragments could yield a functional RNA product such as a ribozyme. These findings showcase the potential role of TNA as a primordial catalyst during the emergence of the RNA world, as well as its prospective application in RNA synthesis.


  • Open Access

    Converting TCR-based chimeric antigen receptor STAR into dual-specific targeting receptor for cancer immunotherapy

    by Li Yu, Zhixiao Zhou, Hanyang Yu, Yue Liu, Daosheng Huang, Jiasheng Wang, Xin Lin


  • Spatially Preorganized Hybridization Chain Reaction for the Prompt Diagnosis of Inflammation

    by Bin Jia, Jingru Ge, Yuxuan Ma, Xiaolei Sun, Zhe Li, Shuoxing Jiang, Hanyang Yu

    Biological systems utilize precise spatial organization to facilitate and regulate information transmission within signaling networks. Inspired by this, artificial scaffolds that enable delicate spatial arrangements are desirable to increase the local concentration of reactants, expedite specific interactions, and minimize undesired interference. In this study, we presented an integrated biosensing nanodevice, termed TRI‐HCR, in which hybridization chain reaction (HCR) probes were precisely organized on a triangular DNA origami nanostructure (TRI) with finely‐tuned distance, quantity, and pattern. Compared to traditional HCR in the free form, this nanodevice demonstrated increased reaction rate and signal level. We further employed the optimized TRI‐HCR for in vivo imaging of a nucleic acid biomarker of inflammatory diseases. In both acute gouty arthritis (AGA) and sepsis‐associated acute kidney injury (SA‐AKI) model mice, TRI‐HCR was capable of diagnosing inflammation in the early stages, significantly earlier than histological examination. We anticipate that this precise spatial preorganization strategy for HCR holds promise for broader applications in early disease detection and monitoring.


  • Spatially Preorganized Hybridization Chain Reaction for the Prompt Diagnosis of Inflammation

    by Bin Jia, Jingru Ge, Yuxuan Ma, Xiaolei Sun, Zhe Li, Shuoxing Jiang, Hanyang Yu

    Biological systems utilize precise spatial organization to facilitate and regulate information transmission within signaling networks. Inspired by this, artificial scaffolds that enable delicate spatial arrangements are desirable to increase the local concentration of reactants, expedite specific interactions, and minimize undesired interference. In this study, we presented an integrated biosensing nanodevice, termed TRI‐HCR, in which hybridization chain reaction (HCR) probes were precisely organized on a triangular DNA origami nanostructure (TRI) with finely‐tuned distance, quantity, and pattern. Compared to traditional HCR in the free form, this nanodevice demonstrated increased reaction rate and signal level. We further employed the optimized TRI‐HCR for in vivo imaging of a nucleic acid biomarker of inflammatory diseases. In both acute gouty arthritis (AGA) and sepsis‐associated acute kidney injury (SA‐AKI) model mice, TRI‐HCR was capable of diagnosing inflammation in the early stages, significantly earlier than histological examination. We anticipate that this precise spatial preorganization strategy for HCR holds promise for broader applications in early disease detection and monitoring.